Clinical trials: Noncellular regenerative approaches

Vjura Senthilnathan, Nayaab Punjani, Narihito Nagoshi, Christopher S. Ahuja, Michael G. Fehlings

研究成果: Chapter

抄録

This chapter will provide an overview of the current noncellular regenerative therapies used in clinical trials as part of treating spinal cord injury (SCI). These methods include the use of antibodies, growth factors, minerals, drugs, biomaterials, and electrical stimulation, which aim to assist the endogenous regenerative circuitry to promote repair and replacement of cellular loss and axonal discontinuity. Most treatments demonstrate safety and feasibility for implementation in SCI; however, further testing is still required to determine efficacy in different clinical subpopulations. This chapter delves into clinical trial phases one to three, as well as humanitarian device exemption studies, with a focus on those from North America, Europe, Japan, and Australia. The trial objectives, main inclusion criteria, and available published results are examined.

本文言語English
ホスト出版物のタイトルNeural Repair and Regeneration after Spinal Cord Injury and Spine Trauma
出版社Elsevier
ページ473-500
ページ数28
ISBN(電子版)9780128198353
ISBN(印刷版)9780128198360
DOI
出版ステータスPublished - 2022 1月 1

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「Clinical trials: Noncellular regenerative approaches」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル